kepivance
swedish orphan biovitrum ab (publ) - palifermin - mucositis - all other therapeutic products - kepivance is indicated to decrease the incidence, duration and severity of oral mucositis in adult patients with haematological malignancies receiving myeloablative radiochemotherapy associated with a high incidence of severe mucositis and requiring autologous-haematopoietic-stem-cell support.
kineret 100mg0.67ml solution for injection pre-filled syringes
swedish orphan biovitrum ltd - anakinra - solution for injection - 150mg/1ml
relistor 12mg0.6ml solution for injection vials
swedish orphan biovitrum ltd - methylnaltrexone bromide - solution for injection - 20mg/1ml
xiapex 0.9mg powder and solvent for solution for injection vials
swedish orphan biovitrum ltd - collagenase clostridium histolyticum - powder and solvent for solution for injection - 900microgram
elocta 1,000unit powder and solvent for solution for injection vials
swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 1000unit
elocta 1,500unit powder and solvent for solution for injection vials
swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 1500unit
elocta 2,000unit powder and solvent for solution for injection vials
swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 2000unit
elocta 250unit powder and solvent for solution for injection vials
swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 250unit
elocta 3,000unit powder and solvent for solution for injection vials
swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 3000unit
elocta 500unit powder and solvent for solution for injection vials
swedish orphan biovitrum ltd - efmoroctocog alfa - powder and solvent for solution for injection - 500unit